Mechanisms of cancer‐associated thrombosis
Open Access
- 30 June 2019
- journal article
- editorial
- Published by Wiley in HemaSphere
- Vol. 3 (S2) , 19-21
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Inhibition of platelet activation prevents the P‐selectin and integrin‐dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivoInternational Journal of Cancer, 2014
- Tissue Factor–Activated Coagulation Cascade in the Tumor Microenvironment Is Critical for Tumor Progression and an Effective Target for TherapyCancer Research, 2011
- Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motilityBMC Cancer, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Tissue factor in cancer progression and angiogenesisThrombosis Research, 2010
- Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivoJournal of Experimental Medicine, 2009
- Microparticle-associated tissue factor activity in cancer patients with and without thrombosisJournal of Thrombosis and Haemostasis, 2009
- Trousseau's syndrome: multiple definitions and multiple mechanismsBlood, 2007
- Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic CancerClinical Cancer Research, 2007
- Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common CancersArchives of internal medicine (1960), 2006